ARM-201 (ARCE Therapeutics)

N/A

Report date: 2025/02/20 16:46:47

Base Information

Drug NameARM-201 (ARCE Therapeutics)
Drug Alias NameARM-201
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSolid tumoursProstatic Neoplasms, Castration-ResistantPancreatic Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesARCE Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesARCE Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursProstatic Neoplasms, Castration-ResistantPancreatic Neoplasms +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A